Global Immune Thrombocytopenia market size is expected to reach $4.72 Billion by 2030 at 5.5%, rise in autoimmune diseases driving the growth of the market due to increasing platelet destruction
Read More
The Immune Response Testing market will reach $26.76 billion by 2030 at 10.3%, driven by rising vaccine monitoring, immunotherapy adoption, at-home test kits
Read More
Global Image-Guided Radiation Therapy market size is expected to reach $2.48 billion by 2030 at 4.4%, segmented as by 4d gating and 4d rt, 4d gating systems, 4d radiation therapy systems
Read More
Global Image Guided And Robotic Assisted Procedures market size is expected to reach $11.17 billion by 2030 at 15.5%, surge in rising prevalence of neurological disorders fueling the growth of market due to increasing demand for precise and minimally invasive treatments
Read More
Global Idiopathic Pulmonary Fibrosis market size is expected to reach $6.16 billion by 2030 at 7.2%, surge in fibrotic diseases propels growth of idiopathic pulmonary fibrosis market
Read More
Global Idiopathic Intracranial Hypertension Treatment market size is expected to reach $2.01 billion by 2030 at 6.3%, rising prevalence of obesity driving growth of the market due to its role in increasing intracranial pressure
Read More
An Important Factor Driving the ICU Beds Market Is the Rising Covid-19 Drives Icu Beds Market Growth
The ICU beds market is projected to reach $3.35 billion by 2030, growing at 8.7% CAGR, driven by smart hospital initiatives, connected devices, and demand for neonatal and pediatric ICU beds.
Read More
Global Hysteroscopy Procedures market size is expected to reach $6.23 billion by 2030 at 7.6%, growing prevalence of gynecological problems fuels expansion of the hysteroscopy procedure market
Read More
Global Hypophosphatasia Treatment market size is expected to reach $3.88 billion by 2030 at 5.6%, the role of increasing biomedical research investments in driving hypophosphatasia treatment market growth
Read More
Global Hypertrophic Cardiomyopathy Treatment market size is expected to reach $1.81 billion by 2030 at 5.4%, segmented as by obstructive hypertrophic cardiomyopathy treatment, medications, surgical procedures, alcohol septal ablation
Read More